Gilead Sciences, Inc.
COMPOUNDS FOR INHIBITION OF ALPHA 4 BETA 7 INTEGRIN

Last updated:

Abstract:

The present disclosure provides a compound of Formula (I): ##STR00001## or a pharmaceutically acceptable salt thereof as described herein. The present disclosure also provides pharmaceutical compositions comprising a compound of Formula (I), processes for preparing compounds of Formula (I), therapeutic methods for treating inflammatory disease.

Status:
Application
Type:

Utility

Filling date:

12 Aug 2020

Issue date:

25 Feb 2021